Texas Senate Bill 1107 (now TEC 51.9192) requires all students entering an institution of higher education (public and private) to either receive a vaccination against bacterial meningitis or meet certain criteria for declining such a vaccination before the first day of the semester.
NOTICE: The law does not specify which Meningitis vaccine students must receive. The vaccine covering types A, C, W, Y (Menveo, Menactra) is the vaccine that covers the predominant strains of bacteria causing meningitis in this region. It is the most common meningitis vaccine that is currently administered. The Meningitis B vaccine (Trumenba, Bexsero) is available as well. While Meningitis B is less common in this region, outbreaks on college campuses in other parts of the country have occurred. Students and parents should discuss with their healthcare provider which vaccines are most appropriate for their own circumstance. For additional information regarding the variances in Meningitis vaccines, please visit the CDC Meningitis Vaccine website.
Texas A&M is partnering with Med+Proctor for the submission of bacterial meningitis vaccination records. For additional information regarding the Meningitis vaccination, please visit the Admissions website or click on the Med+Proctor link.
To assist the Texas A&M University Admissions Department with the Meningitis vaccination process, both incoming and current students may receive a Meningitis vaccination at Student Health Services. Please contact Patient Services at (979) 458-8310 for more information. If the student has proof of the vaccination, the student may email that record to email@example.com or fax to (979) 458-8319 for review and hold removal.